Emerson Electric Co. vs Hinge Health Inc. Class A Common Stock — how do they compare? Emerson Electric Co. trades at $160.9 (market cap $91.20B), while Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B). The key difference: Emerson Electric Co. is far larger — about 10.8× Hinge Health Inc. Class A Common Stock's market cap, and Emerson Electric Co. pays a 1.36% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Emerson Electric Co. for 81 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| EMR | HNGE | |
|---|---|---|
Market Cap | $91.20B | $8.48B |
Volume | 2,131,741 | 879,799 |
Sector | Industrials | Health |
52-Week High | $164.38 | $105.14 |
52-Week Low | $123.30 | $31.17 |
Typical Hold Time | 81 Days | 0 Days |
Enterprise Value | $102.28B | $8.10B |
Dividend Yield | 1.36% | — |
Signals from Pluang's Aura AI — not financial advice
Emerson Electric (EMR) trades at $161.08, down 0.85% on the day, with a bullish technical signal from moving averages. The company shows solid fundamentals with a 13.83% net income margin and consistent earnings beats in recent quarters. Revenue is projected to grow to $18.6B in 2026, and analysts maintain a consensus buy rating with a $165.90 price target, suggesting modest upside. A dividend of $0.56 per share is scheduled for payment in September 2026.
EMR presents a favorable outlook supported by earnings momentum and analyst optimism, though valuation multiples like a P/E of 35.78 are elevated. Key risks include competitive pressures and macroeconomic sensitivity. The stock's proximity to resistance at $164 may prompt near-term consolidation, but fundamental strength supports long-term growth potential.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Emerson Electric is a multi-industrial conglomerate that operates under two business platforms: automation solutions and commercial and residential solutions. The latter is further subdivided into two operating segments: climate technologies, which sells HVAC and refrigeration products and services as well as tools and home products, which sells tools and compressors, among other products and services. Commercial and residential solutions boasts several household brands, including Copeland and RIDGID. Automation solutions is most known for its process manufacturing solutions, which consists of measurement instrumentation, as well as valves and actuators, among other products and services. Roughly half of the firm's geographic sales take place in the United States.
Read more on EMR →Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →